|
|
|
Volumn 26, Issue 6, 1999, Pages 640-646
|
|
Oral fluoropyrimidines
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
5 ETHYNYLURACIL;
BMS 247616;
CAPECITABINE;
DIHYDROPYRIMIDINE DEHYDROGENASE;
EMITEFUR;
FLUOROPYRIMIDINE;
FOLINIC ACID;
UFT;
UNCLASSIFIED DRUG;
5-ETHYNYLURACIL;
ANTINEOPLASTIC ANTIMETABOLITE;
DEOXYCYTIDINE;
DRUG DERIVATIVE;
ENZYME INHIBITOR;
FLUOROURACIL;
FOLIC ACID ANTAGONIST;
OXIDOREDUCTASE;
OXONIC ACID;
PRODRUG;
PYRIDINE DERIVATIVE;
S 1 (COMBINATION);
TEGAFUR;
UFT(R) DRUG;
URACIL;
ARTICLE;
CANCER CHEMOTHERAPY;
COLORECTAL CANCER;
DRUG BIOAVAILABILITY;
DRUG METABOLISM;
ENZYME INACTIVATION;
GASTROINTESTINAL ABSORPTION;
GASTROINTESTINAL TOXICITY;
HUMAN;
MUCOSA INFLAMMATION;
PRIORITY JOURNAL;
ANIMAL;
COLORECTAL TUMOR;
DRUG ANTAGONISM;
DRUG COMBINATION;
REVIEW;
ANIMALS;
ANTIMETABOLITES, ANTINEOPLASTIC;
COLORECTAL NEOPLASMS;
DEOXYCYTIDINE;
DIHYDROURACIL DEHYDROGENASE (NADP);
DRUG COMBINATIONS;
ENZYME INHIBITORS;
FLUOROURACIL;
FOLIC ACID ANTAGONISTS;
HUMANS;
LEUCOVORIN;
OXIDOREDUCTASES;
OXONIC ACID;
PRODRUGS;
PYRIDINES;
TEGAFUR;
URACIL;
|
|
EID: 0033238019
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (41)
|
|
References (51)
|
